Skip Over Navigation Links
NIH National Institutes of Health, DHHS
NIH Home PageHealth InformationGrants & Funding OpportunitiesNewsResearch Training & Scientific Resources at NIHInstitutes, Centers & OfficesAbout NIH
Building 1
Advanced Search Page

Home > News & Events > NIH Radio > April 2006 Audio Reports

NIH Radio

Quick Links

About NIH Radio

Archived Audio Reports

NIH Podcast

 

Osteoporosis Drug Shown to Protect Older Women from Breast Cancer

Right Click to Download MP3 File

Brief Description:
A drug used to treat osteoporosis has been shown to protect older women against breast cancer.

Transcript:
Akinso: A drug used to treat osteoporosis has been shown to protect older women against breast cancer. The Study of Tamoxifen and Raloxifene, known as STAR, initially showed that the drug raloxifene, currently used to prevent and treat osteoporosis in postmenopausal women, works as well as tamoxifen in reducing the risk of breast cancer for postmenopausal women. Dr. Leslie Ford, Associate Director for Clinical Research in NCI's Division of Cancer Prevention, discussed the findings at a recent teleconference.

Ford: First let me say this is good news for women. This was a major step in our battle against breast cancer. However even with cutting our breast cancer risk in half it got little use because of the rare but serious side effects that we knew occurred with tamoxifen. Now we've been able to show that raloxifene a drug that's already in widespread use to prevent and treat osteoporosis in postmenopausal women has the additional benefit of preventing breast cancer with fewer serious side effects; virtually no increase in uterine cancer and fewer blood clots and cataracts when compared to tamoxifen. It's estimated that about 150,000 postmenopausal women will be diagnosed with breast cancer each year. Well we know that no drug risk free, it's because of the government and the National Cancer Institute's investment in prevention clinical trials research over the past 15 years; that women now have now have a new option for taking action to decrease their risk of breast cancer with fewer side effects.

Akinso: Dr. Ford said that although most drugs carry a varying degree of side effects, tamoxifen and raloxifene are vital options for women who are at risk of breast cancer and want to take action. For more information about STAR, visit www.cancer.gov/star. This is Wally Akinso at the National Institutes of Health Bethesda, Maryland.

Date: 04/21/2006
Reporter:
Wally Akinso
Sound Bite:
Dr. Leslie Ford
Topic:
Breast Cancer
Institute(s): NCI
 

This page was last reviewed on April 20, 2006 .

[ Q&A About NIH | Jobs at NIH | Visitor Information | FOIA ]
[ Telephone & Service Directory | Employee Information | Información en español ]

[ Contact Us | Privacy Notice | Disclaimers | Accessibility | Site Map | Search ]

N I H logo - link to the National Institutes of Health

National Institutes of Health (NIH)
9000 Rockville Pike
Bethesda, Maryland 20892

    H H S logo - link to U. S. Department of Health and Human Services

Department of Health
and Human Services

 

  Link to USA Gov Web Site - The U.S. government's official web portal